ROCK & ASSOCIATES for PRECISION PHARMACY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S. 1406, Saving Access to Compounded Medications for Special Needs Patients Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Health Issues HCR
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Law Enforcement/Crime/Criminal Justice LAW
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.